Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Optic Disk | 2 | 2020 | 420 | 1.010 |
Why?
|
| Retinopathy of Prematurity | 5 | 2022 | 449 | 1.010 |
Why?
|
| Retinal Detachment | 5 | 2020 | 426 | 1.010 |
Why?
|
| Uveal Neoplasms | 2 | 2022 | 343 | 0.990 |
Why?
|
| Chorioretinitis | 2 | 2022 | 43 | 0.970 |
Why?
|
| Limbus Corneae | 2 | 2016 | 144 | 0.920 |
Why?
|
| Trabeculectomy | 2 | 2016 | 174 | 0.910 |
Why?
|
| Retinal Vein Occlusion | 2 | 2022 | 147 | 0.870 |
Why?
|
| Retinal Artery | 1 | 2022 | 109 | 0.730 |
Why?
|
| Neonatal Screening | 3 | 2021 | 619 | 0.710 |
Why?
|
| Aicardi Syndrome | 1 | 2020 | 16 | 0.700 |
Why?
|
| Retinal Artery Occlusion | 1 | 2020 | 82 | 0.680 |
Why?
|
| Retinoschisis | 1 | 2020 | 29 | 0.670 |
Why?
|
| Macula Lutea | 1 | 2020 | 168 | 0.620 |
Why?
|
| Eye Abnormalities | 1 | 2020 | 242 | 0.590 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2019 | 146 | 0.580 |
Why?
|
| Surgical Flaps | 2 | 2016 | 1678 | 0.560 |
Why?
|
| Photosensitizing Agents | 3 | 2017 | 626 | 0.540 |
Why?
|
| Glaucoma | 2 | 2016 | 1194 | 0.520 |
Why?
|
| Alkalies | 1 | 2015 | 45 | 0.500 |
Why?
|
| Physical Examination | 1 | 2021 | 1263 | 0.500 |
Why?
|
| Eye Burns | 1 | 2015 | 64 | 0.490 |
Why?
|
| Burns, Chemical | 1 | 2015 | 123 | 0.470 |
Why?
|
| Sclera | 1 | 2015 | 189 | 0.460 |
Why?
|
| Phosphotransferases (Phosphate Group Acceptor) | 1 | 2014 | 18 | 0.460 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2014 | 85 | 0.440 |
Why?
|
| Ribonucleotides | 1 | 2014 | 114 | 0.440 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2021 | 3501 | 0.430 |
Why?
|
| Cell Cycle | 2 | 2019 | 2920 | 0.420 |
Why?
|
| Conjunctiva | 1 | 2016 | 477 | 0.420 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2021 | 2046 | 0.410 |
Why?
|
| Critical Pathways | 1 | 2015 | 475 | 0.380 |
Why?
|
| Neuroglia | 1 | 2017 | 963 | 0.370 |
Why?
|
| Scleral Buckling | 3 | 2020 | 94 | 0.370 |
Why?
|
| RNA, Neoplasm | 1 | 2014 | 745 | 0.370 |
Why?
|
| Visual Acuity | 9 | 2021 | 2672 | 0.370 |
Why?
|
| Melanoma | 2 | 2022 | 5695 | 0.340 |
Why?
|
| Up-Regulation | 1 | 2019 | 4133 | 0.330 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 8612 | 0.330 |
Why?
|
| Phosphoproteins | 2 | 2017 | 2445 | 0.320 |
Why?
|
| Enzyme Activation | 2 | 2016 | 3584 | 0.320 |
Why?
|
| Vitrectomy | 3 | 2020 | 389 | 0.310 |
Why?
|
| Migraine Disorders | 1 | 2020 | 1712 | 0.300 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2017 | 2898 | 0.290 |
Why?
|
| Optic Nerve | 2 | 2021 | 568 | 0.280 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 1884 | 0.280 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 2057 | 0.240 |
Why?
|
| Intravitreal Injections | 3 | 2021 | 391 | 0.240 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 3690 | 0.230 |
Why?
|
| Syria | 3 | 2021 | 88 | 0.230 |
Why?
|
| Emergency Medical Services | 1 | 2015 | 1937 | 0.220 |
Why?
|
| Ophthalmoscopy | 2 | 2021 | 170 | 0.220 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 5791 | 0.200 |
Why?
|
| Macular Degeneration | 2 | 2021 | 1002 | 0.190 |
Why?
|
| Fluorescein Angiography | 3 | 2022 | 1050 | 0.180 |
Why?
|
| DNA-Binding Proteins | 2 | 2017 | 9601 | 0.180 |
Why?
|
| Choroiditis | 1 | 2020 | 12 | 0.180 |
Why?
|
| Ophthalmia, Sympathetic | 1 | 2020 | 18 | 0.180 |
Why?
|
| Uveomeningoencephalitic Syndrome | 1 | 2020 | 22 | 0.170 |
Why?
|
| Uveitis, Posterior | 1 | 2020 | 45 | 0.170 |
Why?
|
| Fundus Oculi | 1 | 2021 | 543 | 0.170 |
Why?
|
| Lens, Crystalline | 1 | 2022 | 387 | 0.170 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2020 | 93 | 0.160 |
Why?
|
| Telemedicine | 3 | 2022 | 3108 | 0.160 |
Why?
|
| Reflex | 1 | 2021 | 375 | 0.160 |
Why?
|
| Photochemotherapy | 2 | 2017 | 826 | 0.160 |
Why?
|
| Tomography, Optical Coherence | 3 | 2022 | 2877 | 0.160 |
Why?
|
| Syphilis | 1 | 2022 | 243 | 0.160 |
Why?
|
| Eye Infections, Bacterial | 1 | 2022 | 239 | 0.160 |
Why?
|
| Eye Injuries, Penetrating | 1 | 2020 | 121 | 0.160 |
Why?
|
| Wet Macular Degeneration | 1 | 2021 | 158 | 0.160 |
Why?
|
| Myopia | 1 | 2021 | 254 | 0.160 |
Why?
|
| Transcription Factors | 2 | 2017 | 12130 | 0.150 |
Why?
|
| Infant, Newborn | 8 | 2022 | 26381 | 0.150 |
Why?
|
| Eye Injuries | 1 | 2020 | 228 | 0.150 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2017 | 39 | 0.140 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2021 | 658 | 0.140 |
Why?
|
| Retrospective Studies | 13 | 2022 | 81565 | 0.140 |
Why?
|
| Gestational Age | 3 | 2022 | 3616 | 0.140 |
Why?
|
| Infant | 6 | 2022 | 36427 | 0.140 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2017 | 91 | 0.140 |
Why?
|
| Macular Edema | 1 | 2021 | 384 | 0.140 |
Why?
|
| Retina | 2 | 2021 | 2646 | 0.140 |
Why?
|
| Cataract Extraction | 1 | 2021 | 464 | 0.140 |
Why?
|
| Humans | 33 | 2022 | 766117 | 0.140 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2017 | 220 | 0.130 |
Why?
|
| Incidence | 4 | 2022 | 21513 | 0.130 |
Why?
|
| Eye Diseases | 1 | 2021 | 660 | 0.120 |
Why?
|
| Infant, Low Birth Weight | 1 | 2020 | 870 | 0.120 |
Why?
|
| Cataract | 1 | 2021 | 837 | 0.120 |
Why?
|
| Congresses as Topic | 1 | 2020 | 811 | 0.120 |
Why?
|
| Cryosurgery | 1 | 2020 | 479 | 0.120 |
Why?
|
| Mitomycin | 1 | 2015 | 261 | 0.120 |
Why?
|
| Algorithms | 1 | 2015 | 14066 | 0.120 |
Why?
|
| Receptors, CCR2 | 1 | 2016 | 215 | 0.120 |
Why?
|
| Necrosis | 1 | 2019 | 1614 | 0.120 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 694 | 0.110 |
Why?
|
| Infant, Premature | 2 | 2021 | 2121 | 0.110 |
Why?
|
| Ophthalmology | 1 | 2020 | 559 | 0.110 |
Why?
|
| Cornea | 2 | 2022 | 1315 | 0.110 |
Why?
|
| Reoperation | 2 | 2020 | 4309 | 0.100 |
Why?
|
| Inflammation | 4 | 2022 | 10860 | 0.100 |
Why?
|
| Macrophage Activation | 1 | 2016 | 553 | 0.100 |
Why?
|
| Corneal Transplantation | 1 | 2016 | 315 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2021 | 3733 | 0.100 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 594 | 0.100 |
Why?
|
| Retinal Neoplasms | 1 | 2014 | 146 | 0.100 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 1068 | 0.100 |
Why?
|
| Porphyrins | 1 | 2014 | 351 | 0.100 |
Why?
|
| Diabetic Retinopathy | 1 | 2021 | 1294 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 998 | 0.100 |
Why?
|
| Prosthesis Implantation | 1 | 2016 | 594 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2017 | 10433 | 0.090 |
Why?
|
| Retinoblastoma | 1 | 2014 | 316 | 0.090 |
Why?
|
| Light | 1 | 2017 | 1358 | 0.090 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 1107 | 0.090 |
Why?
|
| Fluorouracil | 1 | 2015 | 1648 | 0.090 |
Why?
|
| Corneal Diseases | 1 | 2016 | 535 | 0.090 |
Why?
|
| Female | 15 | 2022 | 396233 | 0.080 |
Why?
|
| Prevalence | 3 | 2021 | 15827 | 0.080 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2017 | 1621 | 0.080 |
Why?
|
| Intraocular Pressure | 1 | 2015 | 1304 | 0.080 |
Why?
|
| Treatment Failure | 1 | 2015 | 2653 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 17071 | 0.080 |
Why?
|
| Databases, Factual | 2 | 2020 | 8062 | 0.070 |
Why?
|
| Cholesterol | 1 | 2017 | 2902 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2016 | 2495 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2014 | 5020 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 3249 | 0.070 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 2662 | 0.070 |
Why?
|
| Antihypertensive Agents | 1 | 2015 | 2028 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 4521 | 0.060 |
Why?
|
| Education, Medical | 1 | 2016 | 1744 | 0.060 |
Why?
|
| Middle Aged | 7 | 2021 | 223083 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 3407 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 8924 | 0.060 |
Why?
|
| Cell Survival | 1 | 2014 | 5747 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2014 | 5881 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14456 | 0.050 |
Why?
|
| Curriculum | 1 | 2016 | 3784 | 0.050 |
Why?
|
| Apoptosis | 1 | 2019 | 9508 | 0.050 |
Why?
|
| Male | 11 | 2021 | 363935 | 0.050 |
Why?
|
| Pandemics | 1 | 2022 | 8725 | 0.050 |
Why?
|
| Pseudophakia | 1 | 2021 | 60 | 0.050 |
Why?
|
| Fovea Centralis | 1 | 2022 | 121 | 0.050 |
Why?
|
| Aged | 5 | 2022 | 171219 | 0.050 |
Why?
|
| Macrophages | 1 | 2016 | 5776 | 0.040 |
Why?
|
| Refraction, Ocular | 1 | 2022 | 188 | 0.040 |
Why?
|
| Follow-Up Studies | 5 | 2021 | 39243 | 0.040 |
Why?
|
| Exudates and Transudates | 1 | 2020 | 174 | 0.040 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2021 | 192 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2021 | 748 | 0.040 |
Why?
|
| Adult | 5 | 2021 | 223139 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 10380 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2017 | 23605 | 0.030 |
Why?
|
| Brazil | 1 | 2021 | 1248 | 0.030 |
Why?
|
| Risk Factors | 2 | 2020 | 74857 | 0.030 |
Why?
|
| Atrophy | 1 | 2021 | 1629 | 0.030 |
Why?
|
| Universities | 1 | 2021 | 1004 | 0.030 |
Why?
|
| Artificial Organs | 1 | 2016 | 149 | 0.030 |
Why?
|
| Mice | 2 | 2019 | 81839 | 0.030 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2017 | 298 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2017 | 699 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2017 | 642 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 59515 | 0.030 |
Why?
|
| Young Adult | 2 | 2021 | 59868 | 0.030 |
Why?
|
| Cell Line | 2 | 2017 | 15546 | 0.030 |
Why?
|
| United States | 4 | 2021 | 72920 | 0.030 |
Why?
|
| Adolescent | 2 | 2021 | 88819 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2017 | 1518 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2020 | 2646 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2016 | 1273 | 0.020 |
Why?
|
| Animals | 2 | 2019 | 168800 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2021 | 24276 | 0.020 |
Why?
|
| Vaccination | 1 | 2021 | 3431 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 2213 | 0.020 |
Why?
|
| Neoplasms | 1 | 2017 | 22344 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2020 | 9657 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2017 | 4263 | 0.020 |
Why?
|
| RNA Interference | 1 | 2016 | 2828 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2017 | 3227 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 3424 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 6102 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10614 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2017 | 3684 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15403 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 4342 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 10737 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2020 | 65219 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 26290 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2022 | 41684 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 11906 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 54812 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2016 | 15808 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 42511 | 0.010 |
Why?
|
Concepts
(195)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_